Rate My Professor Mauricio Tohen

Mauricio Tohen, MD, DrPH, MBA, is University Distinguished Professor and Chairman of the Department of Psychiatry & Behavioral Sciences at the University of New Mexico Health Sciences Center in Albuquerque, New Mexico. He earned his medical degree from the National University of Mexico, Doctor of Public Health in Epidemiology from Harvard University, and Master of Business Administration from Indiana University's Kelley School of Business. Postdoctoral training included a residency in Psychiatry at the University of Toronto, a clinical fellowship in Psychopharmacology at McLean Hospital and Harvard Medical School, and a teaching fellowship in Epidemiology at the Harvard School of Public Health. Early in his career, from 1988 to 1997, Dr. Tohen served as Clinical Director of the Bipolar and Psychotic Disorders Program at McLean Hospital.

Dr. Tohen advanced to Lilly Research Laboratories from 1997 to 2008, attaining the senior scientific rank of Distinguished Lilly Scholar. From 2009 to 2013, he was Professor of Psychiatry, holder of the Krus Endowed Chair, and Head of the Division of Mood and Anxiety Disorders at the University of Texas Health Science Center at San Antonio. He joined the University of New Mexico in 2013 as Department Chairman and was promoted to University Distinguished Professor in 2020. His research, funded by the National Institute of Mental Health and pharmaceutical industry grants, focuses on the epidemiology, outcomes, and treatment of bipolar and psychotic disorders. Dr. Tohen has authored more than 370 original peer-reviewed publications, accumulating over 40,000 citations, and holds editorial roles in prestigious journals. He has co-edited key texts such as Psychiatric Epidemiology (first edition 1995, second 2002, third 2011), Mood Disorders Across the Life Span (1996), Bipolar Psychopharmacotherapy (first edition 2006, second 2011), and Clinical Trial Design Challenges in Mood Disorders (2015). Major honors include the National Service Award in Psychiatric Epidemiology from NIMH and Harvard, NIMH FIRST Award, Pope Award from McLean Hospital, NARSAD Young Investigator Award, Simon Bolivar Award from the American Psychiatric Association, Mogens Schou Award for Education and Teaching from the International Society for Bipolar Disorders, NAMI Exemplary Psychiatrist Award, and selection as one of Thomson Reuters’ World’s Most Influential Scientific Minds in Psychiatry/Psychology (2014). He presided over the International Society for Bipolar Disorders (2010-2012) and American Society of Hispanic Psychiatry (2014-2016), and has served on multiple NIMH grant review committees including Epidemiology and Genetics and Early Phase Clinical Trials.